Evaluation of Atacand® (Candesartan) in Daily Medical Practice

Effects of Angiotensin Converting Enzyme (ACE) Inhibitors Versus Candesartan in Reducing Cardiovascular Events in Primary Treatment of Hypertension

NCT01152567 ·Status: COMPLETED

Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Alternative)

NCT00634400 ·Status: COMPLETED ·Phase: PHASE3

Scandinavian Candesartan Acute Stroke Trial (SCAST)

NCT00120003 ·Status: COMPLETED ·Phase: PHASE3

Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg

NCT00383929 ·Status: COMPLETED ·Phase: PHASE3

Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting Conditions

NCT02006589 ·Status: COMPLETED ·Phase: PHASE1

High Doses of Candesartan Cilexetil on the Reduction of Proteinuria

NCT00242346 ·Status: COMPLETED ·Phase: PHASE3

Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics)

NCT00690612 ·Status: COMPLETED ·Phase: PHASE3

The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension

NCT01135212 ·Status: COMPLETED ·Phase: PHASE3

TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention Trial

NCT00227318 ·Status: COMPLETED ·Phase: PHASE3

Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting Conditions

NCT02006602 ·Status: COMPLETED ·Phase: PHASE1

Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France

NCT00679640 ·Status: COMPLETED

Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension

NCT01289132 ·Status: COMPLETED ·Phase: PHASE2

Candesartan Effect in Second Stage Arterial Hypertension

NCT00621153 ·Status: COMPLETED ·Phase: PHASE4

Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo

NCT00434967 ·Status: COMPLETED ·Phase: PHASE3

Compliance of Patients With Essential Hypertension Treated With Candesartan or Candesartan/Hydrochlorothiazide

NCT00608153 ·Status: COMPLETED

New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering

NCT01609959 ·Status: COMPLETED ·Phase: PHASE4

Azilsartan Circadian and Sleep Pressure

NCT01762501 ·Status: COMPLETED ·Phase: NA

Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients

NCT00573742 ·Status: COMPLETED

Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension

NCT00765947 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone

NCT01456169 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.

NCT00775814 ·Status: COMPLETED ·Phase: PHASE4

The Potential of Candesartan to Retard the Progression of Aortic Stenosis

NCT00699452 ·Status: UNKNOWN ·Phase: PHASE3

CHANCE - Candesartan in Hypertrophic Cardiomyopathy

NCT00430833 ·Status: UNKNOWN ·Phase: PHASE2

Candesartan and Candesartan/ Hydrochlorothiazide in the Treatment of Patients With Hypertension and LVH

NCT00607633 ·Status: COMPLETED

Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo

NCT00282178 ·Status: COMPLETED ·Phase: PHASE2